Hyaluronic Acid and Amino Acid Combination Versus Exercise for Chronic Lateral Epicondylitis
A New Era in the Treatment of Chronic Lateral Epicondylitis: Comparison of Targeted Biological Support Using a Hyaluronic Acid and Amino Acid Combination Versus Exercise Therapy: A Retrospective, Controlled Clinical Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Sivas, Turkey (Türkiye)
- Sivas State Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged between 18 and 70 years.
- Patients diagnosed with Lateral Epicondylitis (LE).
- Presence of symptoms persisting for 6 weeks or longer.
- Patients who were treated with either a 3-dose protocol of Hyaluronic Acid + Amino Acid injection combined with a home exercise program, or a home exercise program alone.
Exclusion Criteria:
- History of rheumatic disease.
- History of malignancy.
- Presence of radiculopathy or neuropathy.
- Presence of peripheral circulatory disorders.
- Congenital or acquired upper extremity deformities.
- History of coagulopathy or current use of warfarin therapy.
- Presence of prosthesis, metal implant, or internal fixator in the elbow region.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Control Group: Home Exercise Program Only
Home exercise program without injection.
|
Standardized home exercise program for chronic lateral epicondylitis.
|
|
Intervention Group: HA+AA Injection + Home Exercise Program
Patients in this retrospective cohort were treated with a targeted biological support injection (Hyaluronic Acid and Amino Acid combination) administered at weeks 0, 2, and 4, in addition to the standardized home exercise program.
|
Standardized home exercise program for chronic lateral epicondylitis.
3-dose injection protocol administered at weeks 0, 2, and 4.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pain Intensity (VAS)
Time Frame: Baseline, Week 4, and Month 3
|
Pain intensity will be measured using a 10-cm Visual Analog Scale (VAS).
|
Baseline, Week 4, and Month 3
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pressure Pain Threshold (Algometry)
Time Frame: Baseline, Week 4, and Month 3
|
Pressure pain threshold over the common extensor tendon will be measured using a handheld algometer.
|
Baseline, Week 4, and Month 3
|
|
Change in Functional Status (PRTEE Score)
Time Frame: Baseline, Week 4, and Month 3
|
Functional disability and pain will be assessed using the Patient-Rated Tennis Elbow Evaluation (PRTEE).
|
Baseline, Week 4, and Month 3
|
|
Change in Grip Strength (Hand Dynamometer)
Time Frame: Baseline, Week 4, and Month 3
|
Grip strength will be measured using a hand-held dynamometer.
Measurements will be recorded in kilograms (kg).
Higher values indicate greater strength.
|
Baseline, Week 4, and Month 3
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HA+AA-LE-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.